Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, explains what happens to tumor tissue after brain surgery and how patients can ask their care team for genomic testing.
|Articles|April 8, 2021
Nominate your Bladder Cancer Beacon of Hope
Listen
0:00 / 0:00
Key Takeaways
- BCAN is launching its first Beacon of Hope Award to recognize extraordinary contributions within the bladder cancer community.
- Community members are encouraged to nominate someone who has meaningfully influenced a patient or caregiver experience and inspired hope.
For the first time ever, BCAN will honor a community-nominated “Beacon of Hope” in someone’s bladder cancer journey.
Advertisement
WHAT IS THE BEACON OF HOPE AWARD?
For the first time ever, BCAN will honor a community-nominated “Beacon of Hope” in someone’s bladder cancer journey. During Bladder Cancer Awareness Month in May, we’re shining a light on those in the bladder cancer community who go the extra mile to make an impact and inspire hope. We are asking people to nominate someone who is their “Beacon of Hope.” The winner will be announced during the May 26, 2021 Ask the Experts event.
Click Here to find out more.
Advertisement
Related to this article
Most people with pancreatic cancer lose weight they didn't mean to. Here is how weight loss from poor digestion differs from cachexia, and what enzymes, eating strategies and appetite medicines can do.
Dr. Rebecca Dent explains how Datroway kept brain metastases in check longer than chemotherapy in triple-negative breast cancer, and what patients should know.
In a study of 8,259 rural Medicare patients with advanced non-small cell lung cancer diagnosed from 2014 to 2019, only 35.9% had tumor gene testing, and those who were tested were more likely to get targeted therapy.
Among U.S. adults with a history of cancer, 45.8% reported drinking alcohol in the past 30 days in both 2016 and 2024, while drinking declined among adults without cancer, according to a study in Cancer Causes & Control of nearly 4 million adults.
Dr. Matteo Lambertini explains how Lynkuet reduced hot flashes in people on endocrine therapy for breast cancer, no matter when their treatment began.
Gita Kwatra, PharmD, MBA, co-founder and CEO of the Glioblastoma Foundation, discusses why every patient with glioblastoma should have their tumor profiled, and what patients can ask their care team.
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
Advertisement
Advertisement
Trending on CURE
1
What Is a Whipple Procedure? Pancreatic Cancer Surgery Explained
2
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
3
Survivor Guilt After a Double Mastectomy for DCIS Breast Cancer
4
Pancreatic Cancer and Enzyme Pills: Why They Matter at Every Meal
5